Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Senseonics Holdings (NY: SENS )

0.3213 -0.0014 (-0.43%)
Streaming Delayed Price Updated: 1:13 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Senseonics Holdings

< Previous 1 2 3 4 5 6 7 8 Next >
Most Active Equity Options For Midday - Monday, Feb. 11
Here are the 20 most active equity options for midday. 
Via Talk Markets
Benzinga's Daily Brief On Trending Tickers For Feb. 11, 2022: Cassava Sciences, Cleveland Cliffs, GameStop, and More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... 
Via Benzinga
41 Stocks Moving In Friday's Mid-Day Session
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations... 
Via Benzinga
Why Are Senseonics Shares Falling Despite FDA OK For Next-Gen Eversense CGM
The FDA has approved Senseonics Holdings Inc's (NYSE: 
Via Benzinga
SENS Stock Alert: Why Is Senseonics Heating Up Today?
SENS stock is up nearly 20% on Wednesday after Senseonics said an FDA decision for its glucose monitoring system is pending. 
Via InvestorPlace
Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook
From Senseonics Holdings, Inc.
Via Business Wire
47 Biggest Movers From Yesterday
Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH... 
Via Benzinga
32 Stocks Moving In Monday's Mid-Day Session
Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) jumped 191.2% to $9.47. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH) shares jumped 51% to $18.... 
Via Benzinga
7 A-Rated Penny Stocks That Are Worth a Gamble Now
The economy is heating up and that's great news for penny stocks because they thrive when the market kicks into high gear. 
Via InvestorPlace
7 Stocks to Buy Under $10 in January
Each of these stocks to buy for January are under $10. They encompass a variety of industries and each score high in Portfolio Grader. 
Via InvestorPlace
34 Stocks Moving In Wednesday's Mid-Day Session
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 49.7% to $15.45 after the company announced it acquired exclusive rights to novel mRNA biomarkers. Data Storage... 
Via Benzinga
Senseonics Expects FDA Nod For Next-Gen Eversense Glucose Monitoring System In Coming Weeks
Issuing an operational update, Senseonics Holdings Inc (NYSE: 
Via Benzinga
Senseonics Announces Equity Grants To Employees Under Inducement Plan
From Senseonics Holdings, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! It's time for another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
21 Stocks Moving in Wednesday's Pre-Market Session
Gainers Wejo Group Ltd (NASDAQ: WEJO) rose 37% to $8.63 in pre-market trading after the company announced a new connected vehicle platform with Microsoft, called Wejo Neural Edge... 
Via Benzinga
Senseonics Announces Business Updates
From Senseonics Holdings, Inc.
Via Business Wire
Eversense NOW Remote Monitoring App for Android Users Receives CE Mark in Europe
From Senseonics Holdings, Inc.
Via Business Wire
7 Top-Rated Penny Stocks for a Happier Holiday Season
In this kind of market one of your best bets is to look toward high quality penny stocks to turbocharge your returns. 
Via InvestorPlace
Topics Economy
Exposures Economy
Even Good Penny Stocks Like Senseonics Aren’t Always Profitable
Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech. 
Via InvestorPlace
Senseonics Holdings, Inc. Reports Third Quarter 2021 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
How Bad Are Senseonics Holdings Common Stock's Earnings? | Return On Capital Employed
Benzinga Pro data, Senseonics Holdings, Inc. Common Stock (AMEX:SENS) reported Q2 sales of $3.29 million. Earnings fell to a loss of $15.89 million, resulting in a 31.34%... 
Via Benzinga
Senseonics to Participate in Upcoming November Investor Conferences
From Senseonics Holdings, Inc.
Via Business Wire
7 Penny Stocks That Could Have an Explosive Year-End
While meme trends are on the wane, these seven penny stocks still stand to make turbocharged moves higher in the short-term. 
Via InvestorPlace
Exposures COVID-19
Senseonics Holdings, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 9, 2021, at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Stock Has a Huge Catalyst you Shouldn’t Sleep On
If its its 180-day Eversense diabetes monitoring product gets approval, SENS stock should shift out of neutral. 
Via InvestorPlace
FDA Approval for Senseonics’ Glucose Monitor Could Double the Stock Price
SENS stock should follow a similar trajectory to DexCom, and if it does, it will likely explode in price following FDA approval. 
Via InvestorPlace
Exposures Product Safety
Senseonics Announces Equity Grants To Employees Under Inducement Plan
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Stock Will Grow With Increased Product Awareness
It has been a long road to commercializing the Eversense platform, but SENS stock holders should be glad to know that progress is being made. 
Via InvestorPlace
18 Stocks Moving in Tuesday's Pre-Market Session
Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44... 
Via Benzinga
Senseonics Ready to Deliver More Than Just Hope?
SENS stock is up 800% in the past 12 months, but a potential FDA approval could give shares a reason to go even higher. 
Via InvestorPlace
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.